Target intelligence / Profile preview

Chromosome 17 open reading frame 75 (C17orf75)

Target
C17orf75
Molecular classification
Other (Protein of unknown or miscellaneous function; predicted component of the WDR11 vesicle-trafficking complex)
01

Overview

Chromosome 17 open reading frame 75 (C17orf75), also known as Protein Njmu-R1 or SRI2, is a human protein-coding gene located at chromosome 17q11.2. The protein is proposed to function as part of a trimeric complex (with FAM91A1 and SRI1) involved in the capture of Golgi-derived vesicles, especially those related to the AB toxin ricin, with cellular localization near the cytosol and Golgi apparatus. C17orf75 is ubiquitously expressed at low-to-moderate levels in human tissues, with higher expression in brain and testis, and demonstrates increased expression in various cancers, making it of interest as a potential cancer biomarker. Its precise function and relevance for therapeutic targeting remain unclear, and currently, there are no known drugs or established disease-modifying roles for this gene or its protein product.

Other names
Protein Njmu-R1NJMU-R1SRI2Sensitization to ricin complex subunit 2Spermatogenesis-related protein5730455P16RikRGD1310429C10h17orf75RIKEN cDNA 5730455P16 gene
02

Biological functions

Intracellular protein transportVesicle tethering to GolgiPossible role in spermatogenesisRegulation of cell proliferation or survival (suggested by expression data in cancer)
03

Disease associations

Cancer (biomarker candidate in several malignancies, including retinoblastoma, oral squamous cell carcinoma, hepatocellular carcinoma)Possible association with Leber congenital amaurosis 1 (database linkage, not mechanism-based)
04

Biomarkers

Potential cancer biomarker (upregulated in retinoblastoma, oral squamous cell carcinoma, and hepatocellular carcinoma for diagnostic or disease state monitoring)

Beyond the preview

Go deeper on Chromosome 17 open reading frame 75 (C17orf75).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 17 open reading frame 75 (C17orf75).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call